MEDP (Medpace Holdings, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by MEDP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-28 | Robert O. Kraft | Director | MIXED | — | — |
| 2026-08-27 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-25 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-24 | Kevin M. Brady | CFO & Treasurer | MIXED | — | — |
| 2026-08-21 | Brian T Carley | Director | Sell | — | — |
| 2026-08-21 | FRED B DAVENPORT JR | Director | MIXED | — | — |
| 2026-08-21 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-14 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-13 | Cornelius P. McCarthy III | Director | Sell | — | — |
| 2026-08-12 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-08-11 | Cornelius P. McCarthy III | Director | MIXED | — | — |
| 2026-07-29 | SUSAN E BURWIG | Exec. VP, Operations | Sell | — | — |
| 2026-07-29 | August J. Troendle | President & CEO | Sell | — | — |
| 2026-07-02 | Cornelius P. McCarthy III | Director | M | — | — |
| 2026-07-02 | Brian T Carley | Director | M | — | — |
| 2026-07-02 | Robert O. Kraft | Director | M | — | — |
| 2026-06-01 | STEPHEN P EWALD | General Counsel & Corp. Secy. | MIXED | — | — |
| 2026-05-18 | Brian T Carley | Director | A | — | — |
| 2026-05-18 | FRED B DAVENPORT JR | Director | A | — | — |
| 2026-05-18 | Femida H. Gwadry-Sridhar | Director | A | — | — |
| 2026-05-18 | Robert O. Kraft | Director | A | — | — |
| 2026-05-18 | Cornelius P. McCarthy III | Director | A | — | — |
| 2026-05-18 | Dani S. Zander | Director | A | — | — |
| 2026-04-28 | Kevin M. Brady | CFO & Treasurer | M | — | — |
| 2026-04-28 | SUSAN E BURWIG | Exec. VP, Operations | A | — | — |
| 2026-04-28 | STEPHEN P EWALD | General Counsel & Corp. Secy. | M | — | — |
| 2026-04-28 | August J. Troendle | CEO | A | — | — |
| 2026-04-02 | Brian T Carley | Director | M | — | — |
| 2026-04-02 | Robert O. Kraft | Director | M | — | — |
| 2026-04-02 | Cornelius P. McCarthy III | Director | M | — | — |
| 2026-03-19 | JESSE J GEIGER | President | MIXED | — | — |
| 2026-03-19 | SUSAN E BURWIG | Exec. VP, Operations | M | — | — |
| 2026-02-18 | STEPHEN P EWALD | General Counsel & Corp. Secy. | M | — | — |
| 2026-02-17 | SUSAN E BURWIG | Exec. VP, Operations | M | — | — |
| 2026-02-17 | Brian T Carley | Director | M | — | — |
| 2026-01-05 | Brian T Carley | Director | M | — | — |
| 2026-01-05 | Robert O. Kraft | Director | M | — | — |
| 2026-01-05 | Cornelius P. McCarthy III | Director | M | — | — |
| 2025-12-09 | SUSAN E BURWIG | Exec. VP, Operations | M | — | — |
| 2025-12-04 | SUSAN E BURWIG | Exec. VP, Operations | M | — | — |
| 2025-12-04 | August J. Troendle | CEO | Sell | — | — |
| 2025-12-03 | August J. Troendle | CEO | Sell | — | — |
| 2025-12-02 | Brian T Carley | Director | A | — | — |
| 2025-12-02 | Robert O. Kraft | Director | A | — | — |
| 2025-12-02 | Cornelius P. McCarthy III | Director | A | — | — |
| 2025-12-01 | August J. Troendle | CEO | Sell | — | — |
| 2025-11-26 | SUSAN E BURWIG | Exec. VP, Operations | Sell | — | — |
| 2025-11-26 | August J. Troendle | CEO | Sell | — | — |
| 2025-11-25 | Kevin M. Brady | CFO & Treasurer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President & CEO | 5,272,913 | — |
| — | 10%+ Owner | 4,833,019 | — |
| — | Exec. VP, Operations | 62,984 | — |
| — | President | 46,707 | — |
| — | General Counsel & Corp. Secy. | 36,692 | — |
| — | Director | 27,825 | — |
| — | CFO & Treasurer | 16,230 | — |
| — | Director | 12,275 | — |
| — | Director | 11,259 | — |
| — | Director | 9,295 | — |
| — | VP, Human Resources | 3,000 | — |
| — | Director | 955 | — |
| — | Director | 598 | — |
| — | Director | 250 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MEDP quote page; the site-wide leaderboard is on the insider transactions hub.